Recombinant Human SENP7

Recombinant Human SENP7

Size1:10μg price1:$136
Size2:50μg price2:$378
Size3:500μg price3:$1890
SKU: PEH1491 Category: Target Proteins Tags: ,

Datasheet

Name

Recombinant Human SENP7

Purity

Greater than 95% as determined by reducing SDS-PAGE

Endotoxin level

<1 EU/µg as determined by LAL test.

Construction

Recombinant Human Sentrin-Specific Protease 7 is produced by our E.coli expression system and the target gene encoding Met695-Ala864 is expressed.

Accession #

Q9BQF6

Host

E.coli

Species

Human

Predicted Molecular Mass

19.8 KDa

Buffer

Supplied as a 0.2 μm filtered solution of 20mM HEPES, 5% Glycerol, pH 7.4.

Form

Liquid

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

 

 

 

Alternative Names

Sentrin-Specific Protease 7; SUMO-1-Specific Protease 2; Sentrin/SUMO-Specific Protease SENP7; SENP7; KIAA1707; SSP2; SUSP2

 

Background

Sentrin-Specific Protease 7 (SENP7) acts as a SUMO-2/3-specific protease. SENP7 is likely to regulate the metabolism of poly-SUMO-2/3 rather than SUMO-1 conjugation in vivo. SENP7 has a restricted substrate specificity, and displaying paralogue-specific isopeptidase activity. The C-terminal catalytic domain of SENP7 depolymerized poly-SUMO-2 chains but does not have activity against poly-SUMO-1 chains. SENP7 also had isopeptidase activity against di-SUMO-2- and SUMO-2-modified RanGAP1 (Ran GTPase-activating protein 1) but had limited activity against SUMO-1-modified RanGAP1.

 

Note

For Research Use Only , Not for Diagnostic Use.